SMMT returns by year
Summit Therapeutics Inc. Common Stock has returned +0.6% annually (CAGR) since 2016. Calendar-year, monthly and weekly total returns for Summit Therapeutics Inc. Common Stock (SMMT) below, through August 14, 2026 — the most recent year is year-to-date.
Summit Therapeutics Inc. Common Stock returns by year (2016–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $17.49 | $13.32 | +0.0% | -23.8% | |
| 2025 | $17.85 | $17.49 | +0.0% | -2.0% | |
| 2024 | $2.61 | $17.85 | +0.0% | +583.7% | |
| 2023 | $4.25 | $2.61 | +0.0% | -38.6% | |
| 2022 | $2.69 | $4.25 | +0.0% | +58.0% | |
| 2021 | $4.70 | $2.69 | +0.0% | -42.8% | |
| 2020 | $1.60 | $4.70 | +0.0% | +193.8% | |
| 2019 | $1.15 | $1.60 | +0.0% | +39.1% | |
| 2018 | $11.08 | $1.15 | +0.0% | -89.6% | |
| 2017 | $8.56 | $11.08 | +0.0% | +29.4% | |
| 2016 | $11.50 | $8.56 | +0.0% | -25.6% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from SMMT's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is Summit Therapeutics Inc. Common Stock's average annual return?
- Since 2016, Summit Therapeutics Inc. Common Stock (SMMT) has returned about 0.6% a year (the compound annual growth rate) and an average calendar-year return of 70.5%.
- What were Summit Therapeutics Inc. Common Stock's best and worst years?
- Over 2016–2026, the best year was 2024 (+583.7%) and the worst was 2018 (-89.6%).
- How often is Summit Therapeutics Inc. Common Stock up in a year?
- 5 of the 10 full years since 2016 were positive — about 50% of the time.